Drugs Made In America Acquisition Corp. - DMAA
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Aug 14, 2026 | SCHEDULE 13G/A | KARPUS MANAGEMENT, INC. | 10.33% | 2,507,817 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | First Trust Merger Arbitrage Fund | 2.78% | 675,366 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | First Trust Capital Management L.P. | 3.24% | 786,459 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | First Trust Capital Solutions L.P. | 3.24% | 786,459 | View |
| Aug 14, 2026 | SCHEDULE 13G/A | FTCS Sub GP LLC | 3.24% | 786,459 | View |
| Aug 13, 2026 | SCHEDULE 13G/A | Glazer Capital, LLC | 4.12% | 999,899 | View |
| Aug 13, 2026 | SCHEDULE 13G/A | Paul J. Glazer | 4.12% | 999,899 | View |
| Aug 13, 2026 | SCHEDULE 13G/A | Mizuho Financial Group, Inc. | 8.5% | 2,058,605 | View |
| Jun 26, 2026 | SCHEDULE 13G | Feis Equities LLC | 5.08% | 1,232,775 | View |
| Jun 26, 2026 | SCHEDULE 13G | Lawrence M. Feis | 5.08% | 1,232,775 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.